ProQR Therapeutics (PRQR) Receivables - Net (2022 - 2025)

ProQR Therapeutics' Receivables - Net history runs 3 years deep, the most recent figure standing at $7.9 million for Q4 2025.

• In Q4 2025, Receivables - Net rose 97.69% year-over-year to $7.9 million; the TTM figure through Dec 2025 stood at $7.9 million (up 97.69% YoY), while the FY2025 annual figure was $7.9 million, up 97.69% from the prior year.
• Receivables - Net came in at $7.9 million for Q4 2025 at ProQR Therapeutics, up from $4.0 million in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $57.4 million in Q4 2022 to a low of $4.0 million in Q4 2024.
• A 3-year average of $23.1 million and a median of $7.9 million in 2025 frame the typical range for Receivables - Net.
• On a YoY basis, Receivables - Net climbed as much as 97.69% in 2025 and fell as far as 97.69% in 2025.
• ProQR Therapeutics' Receivables - Net stood at $57.4 million in 2022, then slumped by 93.02% to $4.0 million in 2024, then jumped by 97.69% to $7.9 million in 2025.
• According to Business Quant data, Receivables - Net over the past three periods registered $7.9 million, $4.0 million, and $57.4 million for Q4 2025, Q4 2024, and Q4 2022 respectively.

Peer Comparison